Cyclosporine-related hypercoagulability: fact or fiction?
Edwards
C M
CM
Department of Surgery, Leicester University, UK.
Morgan
J D
JD
Donnelly
P K
PK
D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000009:adverse effects* / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage; D011183:Postoperative Complications / Q000276:immunology / Q000517:prevention & control*; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies; D013916:Thrombelastography; D013923:Thromboembolism / Q000139:chemically induced* / Q000276:immunology
D016572:Cyclosporine; D009543:Nifedipine; D001379:Azathioprine; D011241:Prednisone